Key Points
Unisound AI (9678.HK) drops 4.4% to HK$286.6 amid AI sector volatility.
Stock trades below 50-day and 200-day averages with negative EPS of -HK$5.37.
Meyka AI rates 9678.HK as HOLD with B-grade; monthly target HK$455.05 implies 58.8% upside.
UniBrain platform targets smart healthcare and smart life applications in competitive China AI market.
Unisound AI Technology Co Ltd. (9678.HK) slipped 4.4% to HK$286.6 on Friday, extending a broader pullback in artificial intelligence stocks across Hong Kong. The Beijing-based large language model developer, which listed just under a year ago, is now trading significantly below its 50-day average of HK$301.41. The decline reflects growing investor caution around AI valuations despite the company’s focus on commercializing AGI technology through its UniBrain platform for smart life and healthcare applications.
9678.HK Stock Performance and Technical Weakness
Unisound AI’s HK$13.2 decline marks the fifth consecutive day of losses, with the stock now down 7.5% over five trading days. The company trades below both its 50-day average of HK$301.41 and 200-day average of HK$446.37, signaling sustained downward momentum.
Technical indicators paint a bearish picture. The Relative Strength Index (RSI) sits at 43.93, approaching oversold territory, while the MACD histogram remains negative at -2.61. Volume has contracted sharply to 199,584 shares versus the 593,276 average, suggesting weak conviction among buyers. The stock’s year-to-date decline of 29.1% reflects a dramatic repricing from its 52-week high of HK$879.
Market Cap and Valuation Concerns in AI Sector
Despite the pullback, Unisound AI maintains a HK$20.4 billion market capitalization, positioning it among Hong Kong’s larger technology plays. However, the company’s negative earnings per share of -HK$5.37 and inverted PE ratio of -53.37 highlight ongoing profitability challenges as it scales its AGI research and development.
The Technology sector on HKSE has underperformed, with the broader index down 1.59% today. Investors are reassessing growth-stage AI companies after months of euphoria. Track 9678.HK on Meyka for real-time updates on this critical inflection point for the company’s commercialization roadmap.
Meyka AI Grade and Price Forecast Outlook
Meyka AI rates 9678.HK with a grade of B, suggesting a HOLD recommendation with a total score of 60.83. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects balanced risk-reward dynamics as the company matures its platform.
Meyka AI’s forecast model projects a monthly price target of HK$455.05, implying 58.8% upside from current levels. However, the yearly forecast of HK$42.13 signals extreme volatility and uncertainty around near-term profitability milestones. These grades are not guaranteed and we are not financial advisors.
UniBrain Platform and Competitive Positioning
Unisound AI’s core asset is its UniBrain technology platform, designed for smart life and smart healthcare applications. The company employs 454 full-time staff focused on AGI commercialization and large language model development. Founded in 2012 and headquartered in Beijing, the firm went public on HKSE in June 2025.
The competitive landscape remains intense. Larger players like Baidu (9888.HK) and Alibaba (9988.HK) dominate China’s AI ecosystem with deeper resources. Unisound’s niche focus on healthcare and smart life applications offers differentiation, but execution risk remains high as the company burns cash to scale its platform.
Final Thoughts
Unisound AI Technology’s 4.4% decline reflects broader market skepticism toward unprofitable AI companies trading on growth narratives. With 9678.HK trading below key moving averages and technical indicators flashing weakness, near-term momentum appears negative. However, the Meyka AI B-grade and 58.8% upside forecast suggest the market may be overreacting to short-term volatility. Investors should monitor quarterly updates on UniBrain platform adoption and path to profitability before adding exposure. The stock remains a speculative play on China’s AGI ambitions rather than a near-term income generator.
FAQs
Unisound AI declined amid broader AI sector weakness on HKSE. Investor concerns about unprofitable AI valuations and the company’s negative EPS of -HK$5.37 pressured the stock below its 50-day average.
UniBrain is Unisound’s proprietary large language model platform targeting smart life and smart healthcare applications, representing the company’s core AGI commercialization strategy.
Meyka AI projects HK$455.05 monthly (58.8% upside) and HK$42.13 yearly targets, reflecting extreme volatility. B-grade suggests HOLD with balanced risk-reward dynamics.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)